Maximize Returns with AI-Powered BEAM Insights

BEAM Forecast

Bearish <—> Bullish

80% Confidence

Bullish Case: Beam's gene-editing technology has shown promising trial results in sickle cell therapy, potentially leading to partnerships and revenue growth.

Bearish Case: Intense competition in the gene-editing sector and regulatory hurdles present risks, potentially impacting BEAM's commercial prospects.

Potential Outcomes:

1. Clinical success (40%): Stock rises.

2. Competitive pressure (25%): Price decline.

3. Regulatory setback (15%): Volatility spike.

4. Partner deals (20%): Stock boost.

Trading Oracle: Trade a bullish long call debit spread. Buy the BEAM 28.00 call and sell the 32.00 call, expiring May 2025. This strategy leverages implied volatility and potential trial success for a high reward:risk ratio.

January 31, 2025

Beam Therapeutics Forecast

BEAM Beam Therapeutics

Price Forecast
Future Uncertainty

4 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

9 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

20 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

36 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

49 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

See Longer Forecasts

Correlated Assets

Assets that tend to move strongly with BEAM

ARKG ARK Investment Management LLC - ARK Genomic Revolution (0.74)

ODFL Old Dominion Freight Line (0.63)

DV DoubleVerify (0.63)

CWH Camping World (0.63)

VTRS Viatris (0.6)

Uncorrelated Assets

Assets with little price relationship to BEAM

SRPT Sarepta Therapeutics (0.0)

ROIV Roivant Sciences (0.0)

MHK Mohawk Industries (-0.0)

MFA MFA Financial (-0.0)

FXE Invesco CurrencyShares Euro (-0.01)

Anticorrelated Assets

Assets that tend to move strongly against BEAM

SU Suncor Energy (-0.47)

FCX Freeport-McMoRan (-0.48)

ACB Aurora Cannabis (-0.48)

KDP Keurig Dr Pepper (-0.54)

UVXY ProShares Ultra VIX Short-Term Futures (-0.69)

Become a more profitable investor with AI optimized trading strategies

Market Forecasts

Bullish / Bearish

Digital Assets / Most Accurate

Trading Strategies

Long Volatility

Short Volatility

Balanced News

Balanced News / Sources

Tech / Memes / Politics

About

About / Pricing / Forum

Contact Helium Trades

2024 © Helium Trades
Privacy Policy & Disclosure

* Disclaimer: Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions, you should consult a financial expert before engaging in any transaction.